State ordering guide
Sourcing Exosomes in Arizona
Licensed Arizona practices order Kimera exosome material from ExaVeyra as research-grade product, shipped cold-chain from Miami Beach with a Certificate of Analysis and lot traceability on every vial. Arizona buyers need their own professional license and NPI; the nonresident wholesale permit is the supplier’s obligation, not the purchaser’s.
Two Arizona points are worth settling early. The Arizona Stem Cell Therapy Act was vetoed in June 2026 and did not become law, so the state has no stem cell statute despite the attention the bill received. And Arizona grants nurse practitioners full practice authority, which changes who can run a practice here compared with most states.
At a glance
| Question | Answer |
|---|---|
| Does ExaVeyra ship to Arizona? | Yes. Cold-chain from Miami Beach, as we do to all 50 states |
| Cold-chain transit from Miami | 1 to 3 business days |
| State regenerative-medicine statute | None |
| Does that statute reach exosomes? | No. It covers cells and tissues; exosomes are governed federally |
| Physician delegation required to hand off medical acts | No |
| Who holds the wholesale distribution permit | The supplier, not the purchasing practice |
| Last reviewed | 9 August 2026 |
Ordering from Arizona
ExaVeyra ships to licensed practices in all 50 states, Arizona included. Distribution-side licensing is handled by us, so your practice orders against its own professional license and NPI. What varies state to state is not whether product can reach you, but the indications it may be used for under federal law and how Arizona regulates who performs the procedure.
What your practice provides
- An active Arizona professional license in good standing, verifiable through the Arizona Medical Board or the Arizona State Board of Nursing.
- A valid NPI, which ExaVeyra verifies at account setup.
- A signed research-use acknowledgment on file for exosome material.
- An Arizona transaction privilege tax license and exemption certificate (form 5000A) if the practice is purchasing for resale rather than for use in its own operations.
How the state permits wholesale distribution
Arizona casts the widest net of any state covered in these guides. Rule R4-23-607 provides that a person who is not an Arizona resident may not sell or distribute controlled substances, prescription-only drugs or devices, nonprescription drugs, precursor chemicals, or regulated chemicals into Arizona without both a Board-issued nonresident permit and a current equivalent license in the state where they reside. Full-service wholesale applicants also supply a designated representative holding an Arizona fingerprint clearance card. The permit sits with the distributor, not with the purchasing practice.
A.R.S. tit. 32 ch. 18; Ariz. Admin. Code R4-23-607 · Arizona State Board of Pharmacy
Arizona regenerative-medicine law
Arizona has not enacted a statute specific to stem cell or regenerative therapies. Practice in this area is governed by the state's general medical practice and professional licensing rules, alongside federal law.
Arizona came closer than most. Senate Bill 1214, the Arizona Stem Cell Therapy Act, would have allowed physicians to offer certain non-FDA-approved stem cell and birth tissue therapies subject to sourcing, accreditation, advertising-transparency, and informed-consent standards, and would have barred any therapy derived from an aborted fetus or embryo. It advanced through the Senate Health and Human Services Committee and passed the legislature, and the Governor vetoed it on 19 June 2026. Because practices followed the bill closely, it is worth being specific: SB 1214 is not law, and Arizona therefore has no stem cell statute on the books.
How this applies to exosomes
Arizona has no stem cell statute, so there is no state definition to read exosomes into or out of. It is worth noting that even the vetoed SB 1214 was written around stem cells and birth tissue, which are cellular and tissue categories, rather than around acellular vesicles. Exosome products are governed by federal law, under which no exosome product has been approved by the FDA for administration to humans. ExaVeyra supplies Kimera material for topical aesthetic use in clinics and for research applications, with full COA and lot documentation.
Who can handle product in a Arizona practice
Because nurse practitioners hold full practice authority, Arizona has two workable models rather than one. An NP-led practice can order and supervise within NP scope on its own. A physician-led practice delegates in the conventional way, and a physician medical director remains necessary where procedures sit outside NP scope, where non-independent injectors work under delegation, or where a payer or insurer requires one.
| Role | Scope under state law |
|---|---|
| MD / DO | Physicians licensed by the Arizona Medical Board, and osteopathic physicians licensed by the Arizona Board of Osteopathic Examiners, may perform medical acts within their scope and are the source of any delegation to non-independent staff. |
| NP / APRN | Arizona grants nurse practitioners full practice authority under the Nurse Practice Act, so a nurse practitioner may evaluate, diagnose, and treat within their population focus without a supervising physician. That authority is what allows an NP-led practice in Arizona to operate without a physician medical director for services inside NP scope. |
| PA | Physician assistants practice under physician supervision within the scope their supervising physician delegates. |
| RN | Registered nurses may administer treatments under a provider order and within their scope. Arizona limits who may inject neurotoxins to physicians, nurse practitioners, and registered nurses, so unlicensed staff and aestheticians are outside that group. |
Good faith examination
Arizona expects an initial in-person good faith examination of the patient and a written provider order before a medical aesthetic procedure is performed. Standing orders are workable provided the patient has had a good faith examination within the year or on any change in health history. Confirm current expectations with the Arizona Medical Board and the Arizona State Board of Nursing, since this area is governed by board interpretation rather than a single statute.
Ownership and clinic licensing
Arizona has no statute or regulation expressly prohibiting the corporate practice of medicine. The doctrine survives here through common law, traced to two Arizona Supreme Court optometry decisions, Funk Jewelry Co. v. State in 1935 and State ex rel. Board of Optometry v. Sears Roebuck in 1967, neither of which the court has overruled. In practice Arizona permits professional corporations and permits management services arrangements with non-physician entities, while control of medical judgment stays with licensed clinicians. Because the doctrine rests on case law rather than a statute, the boundaries are less crisply drawn than in Texas or New York; confirm your structure with Arizona counsel.
Cold chain into Arizona
Shipments dispatch from our Miami Beach facility under validated temperature monitoring, and delivery into Arizona is scheduled to avoid a weekend hold at the carrier hub.
| Metro | County | Notes |
|---|---|---|
| Phoenix | Maricopa | Largest Arizona market, with dense aesthetic and longevity coverage. |
| Scottsdale | Maricopa | Highest concentration of med spas and concierge practices in the state. |
| Tucson | Pima | Southern Arizona hub with a broad dermatology and orthopedic mix. |
| Mesa | Maricopa | East Valley market served alongside Phoenix. |
| Chandler | Maricopa | Growing aesthetic segment across the southeast Valley. |
| Flagstaff | Coconino | Northern Arizona market with sports medicine demand. |
- Arizona orders of fifteen or more cold-chain units ship free nationwide; see the volume program for current thresholds.
- Inspect the temperature indicator on arrival and contact us before use if the shipment reads outside range.
- Storage and handling conditions for each product are stated on its Certificate of Analysis.
Practice types we supply in Arizona
Arizona licensing and verification
Arizona Medical Board
Physician license verification and board interpretation on delegation.
Arizona State Board of Nursing
Nurse practitioner full practice authority is administered here.
Arizona State Board of Pharmacy, wholesaler permits
Arizona Department of Revenue
Transaction privilege tax licensing and exemption certificates.
Arizona sourcing questions
- Did Arizona pass a stem cell law in 2026?
- No. Senate Bill 1214, the Arizona Stem Cell Therapy Act, passed the legislature and was vetoed by the Governor on 19 June 2026. Arizona has no stem cell statute. Exosome products are governed by federal law, under which no exosome product is FDA-approved for administration to humans.
- Can a nurse practitioner run a practice in Arizona without a medical director?
- Arizona grants nurse practitioners full practice authority, so an NP may evaluate, diagnose, and treat within their population focus without a supervising physician, and an NP-led practice can operate without a physician medical director for services inside NP scope. A medical director is still needed for procedures beyond NP scope, for non-independent injectors working under delegation, and where a payer or insurer requires one.
- Does Arizona prohibit the corporate practice of medicine?
- Not by statute. The doctrine survives through common law, traced to two Arizona Supreme Court optometry decisions from 1935 and 1967 that the court has never overruled. Professional corporations and management services arrangements are workable, with control of medical judgment staying with licensed clinicians. Because the rule rests on case law, the boundaries are less crisply drawn than in Texas or New York, so confirm your structure with Arizona counsel.
- Does my Arizona clinic need a wholesale permit to buy exosomes?
- No. The nonresident wholesale permit under rule R4-23-607 is held by the out-of-state distributor shipping into Arizona, not by the practice buying. Your practice orders against its own professional license and NPI. ExaVeyra handles distribution-side licensing.
- How is Arizona’s permit rule different from other states?
- It is the broadest in these guides. Arizona reaches controlled substances, prescription-only drugs and devices, nonprescription drugs, and precursor and regulated chemicals, and additionally requires the distributor to hold an equivalent license in its home state. Florida, by comparison, requires no wholesale permit for devices at all.
- How long does cold-chain shipping take to Arizona?
- Overnight from our Miami Beach facility once prepared, with preparation taking one to two business days. All exosome shipments travel cold-chain with validated temperature monitoring, and deliveries are scheduled to avoid a weekend hold at the carrier hub.
Sources
Last reviewed 9 August 2026 by ExaVeyra Sciences editorial team. Every claim above links to a primary source.
- Ariz. Admin. Code R4-23-607, nonresident permits (accessed 8 August 2026)
- Arizona State Board of Pharmacy, wholesaler permits (accessed 8 August 2026)
- Arizona SB 1214 (2026) Senate fact sheet (accessed 8 August 2026)
- Arizona SB 1214 (2026) bill text (accessed 8 August 2026)
- Arizona Medical Board (accessed 8 August 2026)
- Arizona State Board of Nursing (accessed 8 August 2026)
- Arizona Department of Revenue (accessed 8 August 2026)
- FDA Public Safety Notification on Exosome Products (accessed 8 August 2026)
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Biomolecular signaling vesicle products distributed by ExaVeyra Sciences are supplied for topical aesthetic treatments in clinics and for medical, molecular biology, and biochemistry research applications, and are not tissue products as defined by FDA guidelines.
This page summarizes publicly available state requirements for licensed practitioner education. It is not legal advice, medical advice, or regulatory guidance, and it does not establish that any particular practice is compliant. Requirements change. Confirm current federal and state obligations with qualified counsel before offering any regenerative service line.